Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Operations (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Cash from Operations for 16 consecutive years, with 3024.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 99.84% to 3024.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4932522.0 through Dec 2025, up 905.72% year-over-year, with the annual reading at 4932522.0 for FY2025, 905.72% up from the prior year.
  • Cash from Operations hit 3024.0 in Q4 2025 for Cumberland Pharmaceuticals, down from 187180.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5235361.0 in Q2 2023 to a low of 2136647.0 in Q1 2024.
  • Historically, Cash from Operations has averaged 1260499.8 across 5 years, with a median of 1138334.5 in 2023.
  • Biggest five-year swings in Cash from Operations: soared 2683.48% in 2022 and later plummeted 842.34% in 2023.
  • Year by year, Cash from Operations stood at 1959680.0 in 2021, then surged by 85.64% to 3638031.0 in 2022, then tumbled by 71.41% to 1040121.0 in 2023, then soared by 83.12% to 1904618.0 in 2024, then plummeted by 99.84% to 3024.0 in 2025.
  • Business Quant data shows Cash from Operations for CPIX at 3024.0 in Q4 2025, 187180.0 in Q3 2025, and 843801.0 in Q2 2025.